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Abstract: The first sequencing of a complete genome was published forty years ago by the
double Nobel Prize in Chemistry winner Frederick Sanger. That corresponded to the small sized
genome of a bacteriophage, but since then there have been many complex organisms whose
DNA have been sequenced. This was possible thanks to continuous advances in the fields of
biochemistry and molecular genetics, but also in other areas such as nanotechnology and computing.
Nowadays, sequencing sensors based on genetic material have little to do with those used by Sanger.
The emergence of mass sequencing sensors, or new generation sequencing (NGS) meant a quantitative
leap both in the volume of genetic material that was able to be sequenced in each trial, as well as in
the time per run and its cost. One can envisage that incoming technologies, already known as fourth
generation sequencing, will continue to cheapen the trials by increasing DNA reading lengths in
each run. All of this would be impossible without sensors and detection systems becoming smaller
and more precise. This article provides a comprehensive overview on sensors for DNA sequencing
developed within the last 40 years.
Keywords: DNA sequencing; next generation sequencing (NGS); pyrosequencing; fluorescence;
semiconductor; nanopore
1. Introduction
Since Avery McLeod and McCarthy’s famous experiment in 1944, in which it was shown that
DNA was the transforming principle [1] and, therefore, the material from which genes were composed,
the knowledge regarding this molecule has not stopped growing. The next major discovery in the
field of molecular genetics was made by Watson and Crick who proposed a double helix as the
structural model for DNA [2]. This led them to establish the central dogma of molecular biology.
Since then, the interest in determining the primary structure of DNA has been growing, so it can be
said that sequencing technology was born as the set of techniques that leads to knowledge about
the order in which the four nucleotides—Adenine, Cytosine, Guanine, and Thymine—are present in
the DNA. The first organism whose complete genome was sequenced in 1977 was the bacteriophage
Phi-X174 [3]. This genome only had 5386 nucleotides distributed in 11 genes, but its sequencing was
a great milestone. Since then, the genomes of a large number of species have been sequenced until,
finally, the first draft of the human genome was presented in 2001 [4]. Figure 1 shows a timeline of the
more important events in the history of DNA sequencing and Figure 2 shows another timeline of the
evolution of each platform in the number of bases read per run.
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Since 1977, the number of articles on DNA sequencing has continued to grow, reaching more 
than 11,000 publications in 2014 and 2015 (Figure 3). In parallel, the cost of sequencing a complete 
human genome has continued to decline, according to data computed by the National Human 
Genome Research Institute (https://www.genome.gov/sequencingcostsdata/) (Figure 4). Figure 4 also 
shows the theoretical reduction imposed by Moore’s Law, which states that the capacity of the 
hardware used for sequencing doubles every two years. However, what is observed is that the 
decrease in the cost of sequencing a human genome does not decrease proportionally, as might be 
expected, but it does so much more abruptly, particularly since 2008. This is due, above all, to the 
introduction of new generation sequencing (NGS) [5]. 
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Since 1977, the number of articles on DNA sequencing has continued to grow, reaching more
than 11,000 publications in 2014 and 2015 (Figure 3). In parallel, the cost of sequencing a complete
human genome has continued to decline, according to data computed by the National Human Genome
Research Institute (https://www.genome.gov/sequencingcostsdata/) (Figure 4). Figure 4 also shows
the theoretical reduction imposed by Moore’s Law, which states that the capacity of the hardware
used for sequencing doubles every two years. However, what is observed is that the decrease in the
cost of sequencing a human genome does not decrease proportionally, as might be expected, but it
does s much more abruptly, particularly since 2008. This is due, above all, to the introduction of new
generation sequencing (NGS) [5].
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Figure 4. The evolution of the cost of sequencing a complete human genome from 2001 to 2015. The 
theoretical reduction predicted by Moore’s Law is also represented with a red line. 
Sequencing of the bacteriophage Phi-X174 and the subsequent DNA sequencing analysis until 
the completion of the sequencing of the human genome were performed using what is known as the 
Sanger dideoxy method or enzymatic chain termination method [6]. This method is still widely used 
today and it is based on the use of dideoxynucleotides (ddNTPs) that block DNA polymerization. 
The dideoxynucleotides are identical to the deoxynucleotides (dNTPs) that the DNA polymerase 
enzyme uses to generate a DNA strand from another template strand, with the difference being that 
the ddNTPs lack a hydroxyl group on the third carbon of the ribose and this causes the enzyme to 
stop the polymerization of the molecule, since it is not able to find the chemical group to anchor the 
next nucleotide. In practice, what is done is to feed the reaction catalyzed by the DNA polymerase 
Figure 3. The number of articles published on DNA sequencing annually since 1977.
Sensors 2017, 17, 588 3 of 15 
 
 
Figure 3. The number of articles publis   NA sequencing annually since 1977. 
 
Figure 4. The evolution of the cost of sequencing a complete human genome from 2001 to 2015. The 
theoretical reduction predicted by Moore’s Law is also represented with a red line. 
Sequencing of the bacteriophage Phi-X174 and the subsequent DNA sequencing analysis until 
the completion of the sequencing of the human genome were performed using what is known as the 
Sanger dideoxy method or enzymatic chain termination method [6]. This method is still widely used 
today and it is based on the use of dideoxynucleotides (ddNTPs) that block DNA polymerization. 
The dideoxynucleotides are identical to the deoxynucleotides (dNTPs) that the DNA polymerase 
enzyme uses to generate a DNA strand from another template strand, with the difference being that 
the ddNTPs lack a hydroxyl group on the third carbon of the ribose and this causes the enzyme to 
stop the polymerization of the molecule, since it is not able to find the chemical group to anchor the 
next nucleotide. In practice, what is done is to feed the reaction catalyzed by the DNA polymerase 
Figure 4. The evolution of the cost of sequencing a complete human genome from 2001 to 2015.
The theoretical reduction predicted by Moore’s Law is also represented with a red line.
Sequencing of the bacteriophage Phi-X174 and the subsequent DNA sequencing analysis until
the completion f the sequenci g of the uman genome were performed using what is known as the
Sanger dideoxy method or enzymatic chain termination method [6]. This method is still widely used
today an it is based on the use of dide xynucleotides (d NTPs) that block D l erization.
The dideoxynucleotides are identical to the deoxynucleotides (dNTPs) that the DNA polymerase
enzyme uses to generate a DNA strand from another template strand, with the difference being that
the ddNTPs lack a hydroxyl group on the third carbon of the ribose nd this causes the enzyme to stop
the polymerization of the molecule, since it is not able to find the chemical group to anchor the next
nucleotide. In practice, what is done is to feed the reaction catalyzed by the DNA polymerase with a
mixture of dNTPs and ddNTPs, so that at each addition of a nucleotide, the enzyme can incorporate
either of them randomly (Figure 5). Additionally, ddNTPs are labeled by a fluorophore molecule,
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so that each time one of them is incorporated, the reaction will stop and the resulting molecule will emit
a signal that will report on the last incorporated nucleotide (Adenine, Thymine, Cytosine, or Guanine),
since each of them are marked with a different fluorophore. Thus, after an adequate number of cycles
of amplification, we will find a number of molecules equal to the number of nucleotides contained
in the DNA fragment to be sequenced, differentiating these molecules from each other by a single
nucleotide [7]. Next, a capillary electrophoresis is performed with these molecules [8], so that they will
be arranged in increasing order of molecular mass, each of which can be identified by the fluorophore
attached to the corresponding ddNTPs terminator of the reaction [9]. The detection is performed by a
Charge-Coupled Device (CCD) spectral detector [10].
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Fluorescence-labeled ddNTPs block DNA amplification.
However, due to the approach of ambitious massive sequencing projects, such as the human
genome project, it was necessary to develop a new technology that would reduce the costs and the time
required to obtain the sequences [11,12]. In this way, New Generation Sequencing (NGS) was born,
a high-performance technology based on the parallelization of the sequencing process, resulting in
the reading of thousands or even millions of sequences simultaneously [13]. At present, there are
eight large massive sequencing platforms (Table 1), which are different from each other in terms of the
method of preparing the te plates for seq encing, the seque cing reaction itself, and the detection
systems sed [14]. In addition, each of these platforms can have different equipment, different levels
of performance, different numbers of readings and, therefore, a different cost for each sequencing
reaction [15].
Table 1. Massive sequencing platforms presently available.
Methods of DNA Sequenc ng Platform
Short-read sequencing
Sequencing by ligatio AB SOLiD (Thermo Fisher)
Complete Genomics (BGI)
Sequencing by synthesis
Cyclic reversible termination (CRT) Illumina
GeneReader (Qiagen)
Single-nucleotide addition (SNA) 454 Roche
Ion Torrent
Single-molecule real-time long read sequencing Pacific Bioscence
Oxford Nanopore
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In any case, there is no doubt that the development of all this technology has necessarily gone
hand in hand with new detection systems for signals and sensors whose sensitivity has continued
to grow [16]. Increased research on NGS, as reflected in Figure 1, can only be understood from the
understanding that the new detection systems have evolved by leaps and bounds. If this had not been
the case, the development of DNA reading systems would not have been possible.
2. Short-Read Sequencing
2.1. 454 Roche Platform
The Roche 454 was the first NGS equipment to be marketed, and its technology is based
on pyrosequencing [17,18]. In this case, the sequencing is carried out by a synthetic process so
that the reading is performed as nucleotides are incorporated into the template strand replication.
Therefore, the methodology is based on the iterative incorporation of each of the four nucleotides.
In this platform, the pyrophosphate molecule that is released during the incorporation of the
nucleotides in the replication of the template DNA is detected, taking advantage of the fact that
the liberated pyrophosphate is proportional to the incorporated nucleotides. The measurement
of the pyrophosphates is carried out by the detection of emitted light, which is a byproduct of
the transformation of luciferin into oxyluciferin—the reaction is performed by an enzyme called
luciferase—and this reaction requires, as a cofactor, the ATP generated by the ATP sulfurylase from
adenosine 5′-phosphate (APS), in the presence of pyrophosphate [19] (Figure 6). In addition, the bases
that are not incorporated in each cycle are eliminated by the action of an apyrase enzyme, to avoid
these residues interfering in later cycles [20]. The reactions are conducted in each of the one million
wells that structure the PicoTiterPlate™ (Branford, CT, USA) plates, and the light generated in the
reaction—with a maximum wavelength of 560 nanometers—is detected by a CCD camera [21]. That is,
the enzymatic cascade that takes place after the incorporation of a dNTP is ultimately responsible for
the produced bioluminescent signal.
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2.2. AB SOLiD Platform
The SOLiD (sequencing by oligonucleotide ligation and detection) platform, like Sanger
sequencing, is based on the detection of fluorescence signals with the difference being that while
in Sanger sequencing a fluorophore is used for each nucleotide, in SOLiD sequencing a fluorophore
is used for a given combination of two nucleotides. That is, each fluorescence signal represents
the binding of two nucleotides. Thus, the raw data obtained cannot be translated into a known
nucleotide sequence because each of the four signals refers to a subset of four nucleotide combinations.
This methodology is based on the sequential ligation of fluorescent probes [22], so that although
only four fluorophores are used for the 16 possible combinations of nucleotides 2 to 2, it is possible
to determine which nucleotide occupies each position thanks to the known color-space technique
(Figure 7a) [23]. In the SOLiD platform, the ligation and detection of the oligonucleotides is carried
out in four steps. In the first step, each fragment to be sequenced hybridizes to one of the 16 labeled
probes that have two bases of a known sequence at positions n and n + 1, followed by a sequence of
degenerate bases. In a second step the probe is cleaved, releasing the end to which the fluorophore
is bound, and leaving a 5′-phosphate group together with five nucleotides, two of which are of a
known sequence. Next, an extension process is carried out, with 10 rounds of hybridization, ligation,
and cleavage. Finally, the completion is performed to start the cycle again, but this time in the
n + 2 position. The fluorescence signal obtained in each measurement should not be proportional
to a determined nucleotide, but it will limit the number of possibilities to four, requiring successive
cycles of ligation to clear the unknowns [24]. Thus, if in the Sanger sequencing the reading of each
position was associated with a fluorescence signal, so that it was automatically translated as soon as it
was produced, in the SOLiD sequencing the reading can only be understood in a set of signals [25].
The color space technique was a novelty that introduced the SOLiD platform and this is only used by
it. In this technique, in contrast to the base space technique of Sanger sequencing, each signal does not
represent one base but two bases in a row. Each nucleotide pair receives a certain color, but as can be
seen in Figure 7b, the color matching for each nucleotide pair is not random. Reverse (e.g., AG and
GA), complementary (e.g., AG and TC), and complementary reverse (e.g., AG and CT) couples are
shared by the same fluorophore. By having an ACGAA sequence (Figure 7b), the first probe will have
AC in its first two positions, the second probe will have CG, the third probe will have GA, and the
fourth probe will have AA. However, there are up to four possible combinations, so we need a second
reading. Considering this, the only possible sequence is the one that throws an ACGAA reading.
The ligation, detection, and cleavage reactions are performed as many times as nucleotides have the
sequence to be determined.
A variation of this method is used by the Complete Genomics (CG) platform, created in 2006 and
acquired in 2013 by the Chinese company BGI-Shenzhen. This is presented as an ideal platform for the
detection of variants in large-scale genetic studies, such as in projects related to the human genome,
given its high precision and low cost [26]. The two main novelties presented with respect to the other
sequencing platforms are the use of DNA nanoboles and the ligation technique by the combinatorial
probes anchor ligation, cPAL. DNA nanoboles (DNBs) are fragments of circularized DNA template,
following the fragmentation with restriction enzymes by the use of directional adapters, so that each
one of them has different density, size, and even affinity properties. Each DNBs contains many copies
of the original DNA template.
cPAL consists of the use of nonamer probes containing degenerate and fluorophore-tagged DNA
fragments attached to the standard anchor sites to read the bases adjacent to the degeneracy by
ligation of these probes (Figure 8). This is achieved by moving from readings of 6–7 base pairs to
readings of 11–12 base pairs. In this way, the CG platform is the only one in which the reading
of the DNA sequences is carried out in solution. The ligation performed in this methodology is
known as unchained, since with the detection of each probe, the system starts a new cycle from zero,
minimizing the background [27] because the unligated probes are washed away. In this platform the
flow cell is imaged by simultaneous high speed detection of the four colors.
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The sequencing by ligation used by the SOLiD and CG platforms presents the enormous advantage
of offering a very high precision in the reading of the sequences (Table 2). This is because each position
is read several times and with different probes. In contrast, they do present some important drawbacks
such as the short reading length obtained or the long time necessary to obtain the results.
Table 2. Comparison of the different sequencing platforms. The data shown refer to the most favorable
conditions for each platform.
Platform Read Length (bp) Accuracy (%) Run Time Bases Per Run (Gb) Cost/Gb
454 Roche 1000 99 24 h 0.54 $10,000
SOLiD 75 99.9 7 d 520 $10
Illumina 300 99.9 3 d 1800 $10
Ion Torrent 400 99 2 h 15 $100
Pacific Bioscence 20,000 90 3 h 12,000 $600
Oxford Nanopore 10,000 90 2 d 42 $1000
bp, base pairs; Gb, gigabase pairs; h, hours; d, days.
2.3. Illumina Platform
In this platform, DNA sequencing is carried out by fluorescence-labeled nucleotide analogs acting
as reversible terminators of the amplification reaction [28]. The idea is similar to that developed to
carry out the Sanger sequencing, with the difference being that in the Illumina platform the blockade of
DNA polymerization is reversible and in the sequencing of Sanger this is irreversible. Another different
feature of this technology is that the clonal amplification in vitro to multiply the number of molecules
to be sequenced is conducted by means of bridge PCR. In this platform, the fragments are joined to
primers immobilized on a solid surface, performing an amplification in situ, generating clusters of DNA
with identical molecules [29] (Figure 9). In each cycle, the four nucleotides of reversible termination
are simultaneously added and incorporated by the polymerase they complement. These nucleotides
are chemically blocked—by substituting the 3′-OH group for a 3′-o-azidomethyl group—to prevent
the polymerase from incorporating more than one nucleotide in each cycle. Upon incorporation of a
nucleotide, a fluorescence signal is output which is measured by total internal reflection fluorescence
(TIRF) using various laser channels. Concerning the next cycle, the nucleotides that have not been
incorporated are washed and the chemical blockade of the 3′ end is removed through the use of
tris-(2-carboxyethyl)-phosphine, to continue the synthesis of the chain [30]. For this reason, they are
cyclic reversible termination nucleotides. Once the fluorescence signal is collected, a new cycle begins,
repeating this dynamic until the sequencing of each fragment is finished. In summary, we could say that
the sequencing reaction is carried out in three steps: addition of nucleotides, imaging, and regeneration
of 3′-OH by fluorophore cleavage.
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As indicated above, the detection system used in the Illumina platform is the Total Internal
Reflection Fluorescence (TIRF), also known as evanescent wave microscopy. Its main advantage over
other systems is that it is able to detect the fluorescence of molecules that are very close to a solid
surface (glass or plastic), and is highly selective [31]. By means of TIRF, it is possible to illuminate a
very thin layer of less than 100 nm in depth, avoiding the excitation of other fluorophores that may be
near but whose emission is not required for the measurement [32].
This same detection system is used by the Qiagen GeneReader platform, which was launched
on the market in 2015, after Qiagen acquired the Intelligent BioSystems CRT platform. The great
contribution of this new platform, and its great advantage, is that it is presented as an all-in-one
platform [33], from the preparation of the samples to the analysis of the results [34]. Another difference,
methodological in nature, is that the group that is blocking the 3′-OH of the nucleotides is not an
O-azidomethyl, as was the case in the Illumina platform, but an O-allyl, and that the regeneration of
the 3′-OH is performed with a mixture of palladium and P(PhSO3Na)3 (TPPTS) in the GeneReader
platform, while in the Illumina platform the regeneration was carried out with the reducing agent tris
(2-carboxyethyl) phosphine (TCEP). Moreover, both the sequencing methodology by cyclic reversible
termination and the detection of the signal by total internal reflection fluorescence (TIRF) are identical
to that of the Illumina platform.
At present, Illumina’s sequencers are the most widely used in the development of massive
sequencing projects. This is not only due to their high precision in sequencing and the low cost of
the Gb (Gigabytes) obtained (Table 3), but also because they have a great variety of equipment in
the market that can adapt to the needs of each project. This ranges from small medium-performance
bench-top units, such as the MiniSeq, to mega equipment used for sequencing projects of whole
genomes in populations, such as the HiSeqX.
Table 3. Pros and cons of each platform.
Platform Pros Cons
454 Roche Long reading length. Low analysis time. Lowcost for small studies
High error rate in homopolymers. Low
performance. High instrumental cost.
High cost per Gb data
SOLiD High throughput. Low cost per Gb data.High accuracy Short reading length. High instrumental cost
Illumina High throughput. Low cost per Gb data.High accuracy Short reading length. High instrumental cost
Ion Torrent Low instrumental and operational cost.Short execution time. Very simple machine
Error rate not very good. Intermediate cost
per Gb data. More hands-on time
Pacific Bioscence Longest reading length available. Shortinstrument execution time
High error rate. High cost per Gb data. Many
methods are still under development
Oxford Nanopore Small, portable, and low cost instrument High error rate. Biased errors. High costper Reading
Gb, gigabase pairs.
2.4. Ion Torrent Platform
The Ion Torrent platform is based on semiconductor technology and it was the first to use
non-optical sensors [35]; so for the first time, the technology used for DNA sequencing eliminates
both optical scanning and dNTPs attached to fluorophores [36]. The process that is performed is
the same as the one used in the construction of integrated circuits in computer chips. This is based
on the complementary metal-oxide-semiconductor (CMOS) process [37], to monitor the detection of
protons (H+) in DNA synthesis, when the incorporated dNTP is complementary to the nucleotide of
the template chain being copied [38]. The great success of this platform consists of the integration of
a chip that has millions of CMOS sensors in its matrix, so that the compilation of all the data can be
performed in an inexpensive and simple way [39]. The second major innovation of this platform was
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the introduction of an electro-chemical ISFET (ion field sensitive transistor) sensor at the bottom of
each well [40], which act as a pH meter that is sensitive to changes in H+ concentration (Figure 10).Sensors 2 17, 17, 588 10 of 15 
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To perform sequ ncing on the Ion Torrent platform, the DNA t mplate is presented n the surface
of a spher (or bead) obtained by a PCR emulsi n [41]. Subsequently, the addition of a single nu eotide
will occu on at a time so it is t necessary to block the dNTP , as in the cas of cyclic reversible
CRT sequencing. In other words, unlike other platforms, in this case the nucleotides that are used
are not chemically modified. Thus, when the nucleotide that has been added is incorporated by the
polymerase into the DNA strand being synthesized, a proton is released and this is detected by the
CMOS-ISFET sensor, generating a signal that is sent to a computer that will process it.
Unlike the Illumina platform, the Ion Torrent platform does not have a large number of devices
on the market. Even so, their sequencers present so e versatility since there are several types of chips
(whic is the support in which th equencing reactio is carried out) t at adapt to the dimensions
of each project. Thus, c ips with yi lds ranging from 50 Mb to 15 Gb can be found. For chip with
the highest throughput, the run time is not more than 7 h, and for lower throughput, th run time is
about 2 h. Therefore, this short time is one of the main advantages of this platform (Table 3). Thanks to
these characteristics, the Ion Torrent platform is finding its niche market in the analysis of gene groups
(diagnosis of polygenic diseases, metagenomics, etc.), i.e., in clinical sequencing.
3. Single-Molecule Real-Time Long Read Sequencing
3.1. Pacific Bioscence Platform
Previous platforms performed sequencing from small DNA fragments—up to 1000 bp on the
454 platfor —that were processed and modified according to the method of reading, whether by
a ligation reaction or by a synthesis reaction. However, there are new platforms, known as third
generation platforms [42], whose obj ctive is the sequencing of simple molecules in real time.
These platforms take adva tage of advances in the field of nanotechnolo y, alth ugh th way in which
they perform the sequencing reaction is different. Their main advantage is that library preparation is
not necessary and sequencing reagents are not needed [43,44].
The Pacific Bioscence platform was the first to carry out this third-generation sequencing,
and DNA is sequenced by a single-molecule real-time (SMRT) synthesis of a single molecule [45]; this is,
to this day, the platform most often used to carry out this type of sequencing. Whereas in the systems
seen so far for the synthesis (SBS) of small fragments, the DNA was fixed so that the polymerase
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could be moved along it to perform the synthesis of the new chain; in the case of the Pacific Bioscence
platform, the polymerase is the one that is fixed to the bottom of an individual picolitre well with a
transparent bottom, so that the DNA has mobility (Figure 11). In this platform, the DNA sequencing is
carried out thanks to nanosensor technology called ZMW, zero-mode waveguide [46], that detects the
signal generated by the incorporation of phosphate-labeled nucleotides to the well, where a single
DNA polymerase replicates the DNA. The sequencing takes place in the ZMW SMRT cell. ZMW are
devices whose size prevents the propagation of light. As a result, visible laser light does not pass
through the ZMW sensors, so that marked nucleotides that are not incorporated by the polymerase and
are located above these sensors do not contribute to the measured signals. These only fluoresce when
they are incorporated by the enzyme and diffuse through the sensor’s ZMW. The incorporation of
each dNTP is continuously displayed with a laser and a camera system that records the signal emitted
during the incorporation into the lower part of the ZMW. Imaging is possible thanks to the action of a
powerful optical system that illuminates individual ZMWs with red and green laser beams from the
bottom of the SMRT cell and the existence of a parallel confocal system that detects the fluorescence
signal from the incorporated nucleotides [47].
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3.2. Oxford Nanopore Platform
Another platform being used for real-time DNA sequencing from a single molecule is the
Oxford Nanopore platform, which uses nanosensors that form channel structures and that carry
the sample to a sensor that allows for the detection of each nucleotide residue present in the
DNA strand [48,49]. This technology is based on tunneli g by creati g pores to s parate two
compartments [50]. Similar tructures are being used for the detection of specific DNA sequences [51].
In this case, it is the molecule that traverses the pore that causes a temporary change in the potential
between the two compartments, and this change allows its identification [52] (Figure 12). Thus,
instead of using a secondary signal such as light, color, or pH to detect read DNA, the nanopore
platform directly detects the composition of a DNA template [53]. The DNA molecule crosses the pore
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thanks to the action of a secondary motor protein, producing an alteration in the potential between both
sides of the pore. These shifts in voltage are characteristic of each DNA sequence [54,55]. The variation
observed in the measured voltage is not only a consequence of the potential change produced by
the passage of a DNA fragment, but also of its duration, so that this measure can be interpreted as
a particular k-mer sequence. A flow cell structure is composed of an application-specific integrated
circuit (ASIC) chip and each one has 512 individual channels that are capable of sequencing more than
60 bp per second. Considering the fact that this technology uses unmodified DNA, it has the advantage
of yielding results very quickly from minimal starting quantities. At present, this platform works with
both nanopores obtained from genetically engineered proteins and fully synthetic nanopores [56].
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Figure 12. Channels used by the Oxford Nanopor l tf r to sequence DNA. The passage of DNA
through the nanopore produces alterations that are easured thanks to the detected voltage changes.
The first prototype of this platform was the Minion and it was launched on the market in 2014.
This one attracted a lot of attention because of its small size and simplicity. Another advantage is that it
does n t de ermi e the DNA sequ nce through secondary elements such as light or H+ concentration,
but it does so directly and in real time.
However, despite the promising potential caused by the launch of simple molecule sequencing
platforms in real time, these still have the great disadvantage of low accuracy. In the future it will
be necessary to combine the best aspects of each platform to have a sequencer that offers complete
genome sequences quickly, cheaply, and simply. At that time, terms like personalized diagnosis,
genomic medicine, or completely individualized medical treatments will become a reality.
4. Conclusions
This manuscript aims to highlight the importance of DNA sequencing sensors describing the state
of art of the topic nd presenti g the avail bili y f ts methods and platforms. Multiple short-read
sequencing platforms w re nalyzed: 454 Roche, AB SOLiD, Complete G nomics, Illumina,
GeneReader, and Ion Torrent. Additionally, two single-molecule real-time long read sequencing
platforms were analyzed: Pacific Bioscence and Oxford Nanopore. One can envisage that incoming
technologies, already known as fourth generation sequencing, will continue to cheapen the cost of
trials while increasing DNA reading lengths in each run. All of this would be impossible without
sensors and detection systems that are becoming smaller and more precise. The evolution of DNA
sequencing sensors along the last 40 years reveals some very impressing results and opens up new
perspectives for science.
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Knowing the sequence of a DNA fragment has multiple uses, such as performing phylogenetic
studies, diagnosing diseases [57], or controlling pathogens. The tools with which all these applications
can be developed are biosensors [58] or DNA sensors. Thanks to these, a particular sequence of
genetic material or an enzymatic activity can be detected in a complex sample. To date, a multitude
of biosensors have been successfully used for applications such as food, for the control of pathogens,
allergens, or toxins [59]. However, the world of biosensors still faces many challenges. The first one is
that the test sample usually contains a very low DNA concentration, therefore a previous amplification
is necessary by means of PCR or another strategy. Other problems are nonspecific amplifications,
which give rise to false positives, or the technical difficulties inherent in the use of nanomaterials.
In this sense, the use of graphene is being presented as a good solution [60] due to its physicochemical
properties, such as its excellent conductivity or high mechanical resistance. Another difficulty that
occurs in the use of biosensors is in the molecular recognition by natural receptors. In this case,
the use of Molecularly Imprinted Polymers (IPM) helps to reduce this problem, providing convenient
solutions [61]. In any case, the use of biosensors is spreading and is expected to maintain its exponential
growth to reach a world with ubiquitous sensors. Therefore, the combination of improvements in both
the molecular field and the study of new materials seem fundamental.
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